Elucidating circular ribonucleic acid mechanisms associated with splicing factor 3 inhibition in cervical cancer

dc.contributor.authorNyalambisa, Amahle
dc.contributor.authorAlabi, Babatunde Adebola
dc.contributor.authorDlamini, Zodwa
dc.contributor.authorMarima, Rahaba
dc.contributor.emailrahaba.marima@up.ac.za
dc.date.accessioned2026-04-08T05:04:07Z
dc.date.available2026-04-08T05:04:07Z
dc.date.issued2025-11-10
dc.descriptionDATA AVAILABILITY STATEMENT : The data supporting this study’s findings are available from the corresponding author, [RM], upon reasonable request.
dc.description.abstractCervical cancer (CCa) is the fourth leading cause of cancer-related deaths among women worldwide, with nearly 90% of cases in low- and middle-income countries, especially in Sub-Saharan Africa. This study explores the roles of circular ribonucleic acids (circRNAs), hsa_circ_0001038 and circRNA_400029, and the impact of the serine/arginine-rich splicing factor 3 (SRSF3) inhibitor, theophylline, in CCa cell lines. We utilized cell cycle fluorescence-activated cell sorting (FACS) and Annexin V/propidium iodide (PI) assays to evaluate theophylline’s effects on SiHa and C33A cell lines. Results showed S-phase arrest in SiHa and G2/M arrest in C33A, with significant cytotoxic effects indicated by apoptosis analysis. Using CircAtlas, we identified micro ribonucleic acids (miRNAs) binding to hsa_circ_0001038, particularly miR-205-5p, which has a tumour-suppressive role. miRTarBase identified miR-16-5p as a key interacting miRNA for circRNA_400029. We constructed a competing endogenous ribonucleic acid (ceRNA) network, revealing multiple miRNA targets. Pathway analysis via the Kyoto Encyclopedia of Genes and Genomes (KEGG) highlighted critical signalling pathways involved in CCa oncogenesis. In conclusion, theophylline demonstrates cytotoxicity in CCa cells, suggesting its potential for repurposing in CCa theranostics, though further optimization is necessary.
dc.description.departmentMedical Oncology
dc.description.librarianam2026
dc.description.sdgSDG-03: Good health and well-being
dc.description.sponsorshipSupported by the South African Medical Research Council (SAMRC), the National Research Foundation (NRF), and the University of Pretoria (UP).
dc.description.urihttps://www.mdpi.com/journal/ijms
dc.identifier.citationNyalambisa, A., Alabi, B.A., Dlamini, Z. & Mojakgomo, R. Elucidating Circular Ribonucleic Acid Mechanisms Associated with Splicing Factor 3 Inhibition in Cervical Cancer. International Journal of Molecular Sciences 2025, 26, 10883: 1-12. https://doi.org/10.3390/ ijms262210883.
dc.identifier.issn1661-6596 (print)
dc.identifier.issn1422-0067 (online)
dc.identifier.other10.3390/ ijms262210883
dc.identifier.urihttp://hdl.handle.net/2263/109450
dc.language.isoen
dc.publisherMDPI
dc.rights© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
dc.subjectCervical cancer
dc.subjectCircular ribonucleic acids
dc.subjectSplicing factor 3
dc.subjecthsa_circ_0001038
dc.subjectcircRNA_400029
dc.subjectAlternative splicing
dc.titleElucidating circular ribonucleic acid mechanisms associated with splicing factor 3 inhibition in cervical cancer
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Nyalambisa_Elucidating_2025.pdf
Size:
2.56 MB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: